Entrapment of recombinant staphylokinase by liposomes: Formulations, preparation, characterization and behavior in vivo

Journal of Drug Delivery Science and Technology

Volumn 18, Issue 4, 2008, Pages 245-251

  Yang, L ^a   Shi, C H ^a   Chang, Y Y ^a   Li, H ^a   Xiao, P ^b   Yang, W Z ^c   Zeng, Q ^b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b Beijing Snowle Biotechnology Limited Corporation   (China)

^c UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

"Lytic circle" method; Bioactivity; Encapsulation; Formulation; Liposomes; Pharmacokinetics; Recombinant staphylokinase

Indexed keywords

ALBUMIN; FIBRINOLYTIC AGENT; LIPOSOME; ORGANIC SOLVENT; RECOMBINANT STAPHYLOKINASE; TRITON X 100; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG DESIGN; DRUG FORMULATION; DRUG HALF LIFE; DRUG STABILITY; DRUG SYNTHESIS; ENCAPSULATION; FIBRINOLYSIS; HIGH TEMPERATURE; IN VIVO STUDY; MALE; NONHUMAN; RAT; ULTRASOUND;

EID: 52649136679     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(08)50048-7     Document Type: Article

References (20)

1. Collen D., Lijnen H.R.- Staphylokinase, afibrin-specific plasminogen activator with therapeutic potential. - Blood, 84, 680-686, 1994.
2. Collen D., Zhao Z.A., Holvoet P., Marynen P. - Primary structure and gene structure of staphylokinase. - Fibrinolysis, 6, 226-231, 1992.
3. Collen D., Schlott B., Engelborghs Y., Van H.B., Hartmann M., Lijnen H.R., Behnke D. - On the mechanism of the activation of human plasminogen by recombinant staphylokinase. - J. Biol. Chem., 268 (11), 8284-8289, 1993.
4. Lijnen H.R., De C.F., Van H.B., Schlott B., Collen D. - Characterization of the interaction between plasminogen and Staphylokinase. - Eur. J. Biochem., 224, 143-149, 1994.
5. Schlott B., Hartmann M., Gührs K.H., Birch-Hirschfeld E., Gase A., Vettermann S., Collen D., Lijnen H.R. - Functional properties of recombinant staphylokinase variants obtained by site-specific mutagenesisof methionine-26.- Biochem.Biophys.Acta., 1204 (2), 235-242, 1994.
6. Vanderschueren S., Stoclot L., Wilms G., Lacroix H.,Verhaeghe R., Vermylen J., Collen D. - Thrombolytic therapy of peripheral arterial occlusion with recombinant staphylokinase. - Circulation, 92, 2050-2057, 1995.
7. Dev B.B., Rajendra N.D., Chaudhari M.R., Kadam S.S. - Plasminogen activators: A comparison. - Vasc. Pharmacol., 44, 1-9, 2006.
8. Storm G., Koppenhagen F., Heeremans A., Vingerhoeds M., Woodle M.C., Crommelin DJA. - Novel developments in liposomal delivery of peptide and proteins. - J. Control. Release, 36 19-24, 1995.
9. Leach J.K., O'Rear E.A., Patterson E., Miao Y., Johnson A. E. - Accelerated thrombolysis in a rabbit model of carotid artery thrombosis with liposome-encapsulated and microencapsulated streptokinase. - Thromb. Haemost., 90 (1), 64-70, 2003.
10. Yang L.,Yang W.Z., Bi D.Z., Zeng Q. - A novel method to prepare highly encapsulated interferon-β-2b containing liposomes for intramuscular sustained release. - Eur. J. Pharm. and Biopharm., 64, 9-15, 2006.
11. Li C.J., Huang J., Shao Z.G., Wang W.Q., Zhang J., Yang G-P., Huang P. - Pharmacolkinetics of native r-Sak in rabbit's femoral artery thrombosis model. - J. Nangjing Med. Univ., 18 (2),89-93, 2004.
12. Rabijns A., De-Bondt H., De-Ranter C. - Three-dimensional structure of staphylokinase, a plasminogen activator with therapeutic potential. - Nat. Struct. Biol., 4, 357-360, 1997.
13. Collen D., Silence K., Demarsin E., De-Mol M., Lijnen H.R. - Isolation and characterization of natural and recombinant staphylokinase. - Fibrinolysis, 6(4), 203-213, 1992.
14. New R.R.C. - Preparation of liposome. - In: Liposomes, a Practical Approach, R.R.C. New Ed., Oxford University Press, 1989, pp. 33-104.
15. Bilati U., Allema E., Doelker E. - Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. - Eur. J. Pharm. and Biopharm., 59, 375-388, 2005.
16. He J.T., Tao X.M., Mo W., Song H.Y. - Preparation and characterization of PLGA microspheres containing a staphylokinase variant (K35R). - Acta Pharm. Sinica., 41 (1), 11-18, 2006.
17. Zhang Y. - Gene- recombinant thrombolytic drugs. - In: Biopharmaceutical Drug Development and Quality Control, J.Z. Wang Ed., Science Press, 2002, pp. 524-525.
18. Tong M.Q., Dai C.Z., Jiang L., Zhao W.S. - A study on pharmacokinetics of recombinant staphylokinase in healthy subjects. - Acta Univ. Med. Nanjing, 20(2), 94-97, 2000.
19. Xu C.J., Liu X., Li D., HuangYB., Yu M., Mo W. - Pharmacokinetics of recombinant staphylokinase in rats after bolus injection. - Fudan Univ. J. Med. Sci., 29 (4), 308-310, 2002.
20. Sim A.K., Mc-Craw A.P., Cleland M.E., Aihara A., Otomo S., Hosoda K., Araki H. - A preclinical assessment of the effect lipo-PGE1 on thrombus formation and thrombus disaggregation. - Adv. Drug Deliv., 20, 165-170, 1996.